You just read:

PEGASUS-TIMI 54 study shows that long-term treatment with BRILINTA reduced thrombotic cardiovascular events in patients with a history of heart attack

News provided by

AstraZeneca Canada Inc.

Mar 16, 2015, 07:00 ET